Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sureda

Showing results (221-230 of 249) with videos related to

Pageof 25
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2014
The impact of total body irradiation on the outcome of patients with follicular lymphoma treated with autologous stem-cell transplantation in the modern era: a retrospective study of the EBMT Lymphoma Working PartyI El-Najjar, A Boumendil, J J Luan, et al.
Bone Marrow Transplantation|November 17, 2015
Thiotepa-based high-dose therapy for autologous stem cell transplantation in lymphoma: a retrospective study from the EBMTL Sellner, A Boumendil, H Finel, et al.
British Journal of Haematology|November 9, 2021
Long-term outcome of patients receiving haematopoietic allogeneic stem cell transplantation as first transplant for high-risk Hodgkin lymphoma: a retrospective analysis from the Lymphoma Working Party-EBMTG Gutiérrez-García, C Martínez, A Boumendil, et al.
Bone Marrow Transplantation|February 5, 2022
The first steps towards a diverse and inclusive EBMT: a position paperS Montoto, J A Snowden, C Chabannon, et al.
Bone Marrow Transplantation|July 30, 2013
Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practiceT Ruutu, A Gratwohl, T de Witte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2013
Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantationC Martínez, C Canals, B Sarina, et al.
Leukemia|January 13, 2006
Reduced-intensity conditioning allogeneic transplantation is associated with a high incidence of extramedullary relapses in multiple myeloma patientsJ A Pérez-Simón, A Sureda, F Fernández-Aviles, et al.
British Journal of Haematology|December 12, 2001
Waldenström macroglobulinaemia: presenting features and outcome in a series with 217 casesR García-Sanz, S Montoto, A Torrequebrada, et al.
Bone Marrow Transplantation|January 9, 2021
Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sézary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow TransplantationE Domingo-Domenech, R F Duarte, A Boumedil, et al.
Bone Marrow Transplantation|August 1, 1997
Autologous stem cell transplantation for poor prognosis Hodgkin's disease in first complete remission: a retrospective study from the Spanish GEL-TAMO cooperative groupA Sureda, R Mataix, F Hernández-Navarro, et al.
Pageof 25

Showing results (221-230 of 249) with videos related to

Sort By:
Pageof 25
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2014
The impact of total body irradiation on the outcome of patients with follicular lymphoma treated with autologous stem-cell transplantation in the modern era: a retrospective study of the EBMT Lymphoma Working PartyI El-Najjar, A Boumendil, J J Luan, et al.
Bone Marrow Transplantation|November 17, 2015
Thiotepa-based high-dose therapy for autologous stem cell transplantation in lymphoma: a retrospective study from the EBMTL Sellner, A Boumendil, H Finel, et al.
British Journal of Haematology|November 9, 2021
Long-term outcome of patients receiving haematopoietic allogeneic stem cell transplantation as first transplant for high-risk Hodgkin lymphoma: a retrospective analysis from the Lymphoma Working Party-EBMTG Gutiérrez-García, C Martínez, A Boumendil, et al.
Bone Marrow Transplantation|February 5, 2022
The first steps towards a diverse and inclusive EBMT: a position paperS Montoto, J A Snowden, C Chabannon, et al.
Bone Marrow Transplantation|July 30, 2013
Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practiceT Ruutu, A Gratwohl, T de Witte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2013
Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantationC Martínez, C Canals, B Sarina, et al.
Leukemia|January 13, 2006
Reduced-intensity conditioning allogeneic transplantation is associated with a high incidence of extramedullary relapses in multiple myeloma patientsJ A Pérez-Simón, A Sureda, F Fernández-Aviles, et al.
British Journal of Haematology|December 12, 2001
Waldenström macroglobulinaemia: presenting features and outcome in a series with 217 casesR García-Sanz, S Montoto, A Torrequebrada, et al.
Bone Marrow Transplantation|January 9, 2021
Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sézary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow TransplantationE Domingo-Domenech, R F Duarte, A Boumedil, et al.
Bone Marrow Transplantation|August 1, 1997
Autologous stem cell transplantation for poor prognosis Hodgkin's disease in first complete remission: a retrospective study from the Spanish GEL-TAMO cooperative groupA Sureda, R Mataix, F Hernández-Navarro, et al.
Pageof 25